Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
6.94
+0.08 (1.17%)
Feb 3, 2026, 3:04 PM CST
SHE:002198 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 127.89 | 336.14 | 135.21 | 185.74 | 242.89 | 144.08 |
Trading Asset Securities | 0.01 | - | 200.53 | 50.26 | - | - |
Cash & Short-Term Investments | 127.91 | 336.14 | 335.74 | 236 | 242.89 | 144.08 |
Cash Growth | -56.94% | 0.12% | 42.26% | -2.83% | 68.58% | 17.80% |
Accounts Receivable | 150.94 | 128.93 | 154.05 | 224.61 | 159.92 | 166.48 |
Other Receivables | 22.81 | 0.7 | 0.09 | 0.51 | -0.03 | 31.97 |
Receivables | 173.75 | 129.91 | 154.3 | 225.27 | 160.06 | 198.6 |
Inventory | 85.39 | 85.06 | 84.6 | 82.28 | 73.36 | 72.8 |
Prepaid Expenses | - | - | - | - | 0.17 | 0.88 |
Other Current Assets | 79.07 | 2.65 | 5.53 | 13.87 | 13.2 | 18.17 |
Total Current Assets | 466.11 | 553.76 | 580.17 | 557.43 | 489.67 | 434.52 |
Property, Plant & Equipment | 205.15 | 209.94 | 190.41 | 203.7 | 224.19 | 245.78 |
Long-Term Investments | 41.37 | 23.3 | 27.09 | 29.38 | 30.59 | 58.27 |
Other Intangible Assets | 46.7 | 45.89 | 47.21 | 52.37 | 58.29 | 64.16 |
Long-Term Deferred Tax Assets | 4.64 | 3.03 | 2.19 | 2.21 | 4.59 | 5.62 |
Long-Term Deferred Charges | 10.76 | 1.4 | - | - | - | - |
Other Long-Term Assets | - | 1.49 | 0.49 | 1.55 | - | 0.09 |
Total Assets | 774.73 | 838.82 | 847.56 | 846.65 | 807.34 | 808.44 |
Accounts Payable | 9.71 | 12.61 | 9.16 | 18.98 | 14.12 | 10.3 |
Accrued Expenses | 4.36 | 12.94 | 21.35 | 21.06 | 16.52 | 10.86 |
Short-Term Debt | - | - | - | - | 31.11 | 20.16 |
Current Income Taxes Payable | 6.5 | 2.86 | 1.93 | 2.19 | 1.07 | 6.71 |
Current Unearned Revenue | 2.74 | 2.88 | 2.21 | 11.12 | 2.56 | 23.99 |
Other Current Liabilities | 7.45 | 14.28 | 14.7 | 29.6 | 22.54 | 18.44 |
Total Current Liabilities | 30.76 | 45.57 | 49.34 | 82.95 | 87.91 | 90.46 |
Long-Term Unearned Revenue | 0.21 | 0.29 | 0.41 | 0.54 | 0.2 | 0.23 |
Long-Term Deferred Tax Liabilities | 34.75 | 34.75 | 34.83 | 34.75 | 34.75 | 34.75 |
Total Liabilities | 65.72 | 80.6 | 84.58 | 118.23 | 122.85 | 125.43 |
Common Stock | 507.51 | 507.51 | 507.51 | 507.51 | 507.51 | 507.51 |
Additional Paid-In Capital | 123.65 | 123.65 | 123.65 | 123.41 | 123.41 | 123.41 |
Retained Earnings | 148.85 | 127.06 | 131.82 | 97.5 | 53.57 | 52.09 |
Shareholders' Equity | 709.01 | 758.22 | 762.98 | 728.42 | 684.48 | 683.01 |
Total Liabilities & Equity | 774.73 | 838.82 | 847.56 | 846.65 | 807.34 | 808.44 |
Total Debt | - | - | - | - | 31.11 | 20.16 |
Net Cash (Debt) | 127.91 | 336.14 | 335.74 | 236 | 211.78 | 123.92 |
Net Cash Growth | -56.94% | 0.12% | 42.26% | 11.44% | 70.91% | 385.41% |
Net Cash Per Share | 0.25 | 0.66 | 0.66 | 0.47 | 0.42 | 0.24 |
Filing Date Shares Outstanding | 509.81 | 507.51 | 507.51 | 507.51 | 507.51 | 507.51 |
Total Common Shares Outstanding | 509.81 | 507.51 | 507.51 | 507.51 | 507.51 | 507.51 |
Working Capital | 435.34 | 508.19 | 530.83 | 474.49 | 401.76 | 344.06 |
Book Value Per Share | 1.39 | 1.49 | 1.50 | 1.44 | 1.35 | 1.35 |
Tangible Book Value | 662.31 | 712.33 | 715.78 | 676.04 | 626.19 | 618.84 |
Tangible Book Value Per Share | 1.30 | 1.40 | 1.41 | 1.33 | 1.23 | 1.22 |
Buildings | - | 285.78 | 279.17 | 277.57 | 279.88 | 279.88 |
Machinery | - | 152.4 | 158.85 | 163.77 | 168.06 | 168.71 |
Construction In Progress | - | 29.06 | 1.66 | - | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.